A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 46
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : EPCs
Long Form : endplate currents
No. Year Title Co-occurring Abbreviation
2019 Reorganization of Septins Modulates Synaptic Transmission at Neuromuscular Junctions. ACh, FCF, GTP, Sept
2017 Muscarinic cholinoreceptors (M1-, M2-, M3- and M4-type) modulate the acetylcholine secretion in the frog neuromuscular junction. ACh
2017 Seasonal factors influence quantal transmitter release and calcium dependence at amphibian neuromuscular junctions. ne, NMJs, pe
2015 Mechanisms of hydrogen sulfide (H2S) action on synaptic transmission at the mouse neuromuscular junction. BAPTA-AM, EGTA-AM, EPPs, MEPPs
2014 Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis. MG, MuSK, NMJs
2011 Opposite modulation of time course of quantal release in two parts of the same synapse by reactive oxygen species. ROS
2010 Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions. DAP, DCH, MEIs, NMPs
2009 Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. AChR, MEPC, NMJ, SMA
2004 Cholinergic regulation of the evoked quantal release at frog neuromuscular junction. ---
10  2003 Effects of Hypericum extract on the acetylcholine release: a loose patch clamp approach. ACh, AChE, LPC
11  2003 Long release latencies are increased by acetylcholine at frog endplate. ---
12  2003 Temperature effect on proximal to distal gradient of quantal release of acetylcholine at frog endplate. ---
13  2002 Inhibition of skeletal muscle nicotinic receptors by the atypical antipsychotic clozapine. ---
14  2002 Protein kinase A cascade regulates quantal release dispersion at frog muscle endplate. ---
15  2002 Reduced endplate currents underlie motor unit dysfunction in canine motor neuron disease. HCSMA
16  2002 Reduced neuromuscular quantal content with normal synaptic release time course and depression in canine motor neuron disease. mEPC, MG
17  2000 Cyclic AMP synchronizes evoked quantal release at frog neuromuscular junctions. db-cAMP, NA
18  1999 Noradrenaline synchronizes evoked quantal release at frog neuromuscular junctions. NA
19  1998 Effect of phenol on the ion currents of frog nerve ending. 4-AP, TEA
20  1997 Desensitization shortens the high-quantal-content endplate current time course in frog muscle with intact cholinesterase. ACh, AChE, MEPCs
21  1997 Hexamethonium- and methyllycaconitine-induced changes in acetylcholine release from rat motor nerve terminals. AChRs, MEPCs, MLA
22  1997 The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles. EDL, EPPs, VGSCs
23  1993 Actions of benzalkonium chloride as a potent depressant at the neuromuscular junction. BA, EPPs, MEPCs
24  1992 A novel peptide toxin from Trimeresurus wagleri acts pre- and post-synaptically to block transmission at the rat neuromuscular junction. ---
25  1992 The effects of vesamicol on trains of endplate currents and on focally recorded nerve terminal currents at mammalian neuromuscular junctions. ACh
26  1991 Acetylcholine recycling and release at rat motor nerve terminals studied using (-)-vesamicol and troxpyrrolium. MECPs
27  1990 Calcium channel effectors are potent non-competitive blockers of acetylcholine receptors. CCEs, nAChR
28  1990 End-plate ion channel block produced by lincosamide antibiotics and their chemical analogs. ---
29  1989 Development of desensitization during repetitive end-plate activity and single end-plate currents in frog muscle. AChE, AChR, MEPCs
30  1989 Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate. ACh, AChR, alpha-BTX, EAMG, EPP, mAbs, MEPPs
31  1989 Temperature and synaptic efficacy in frog skeletal muscle. ---
32  1987 Synaptic depression in frog neuromuscular junction. ACh, MEPCs
33  1986 Augmentation of succinylcholine-induced neuromuscular blockade by calcium channel antagonists. ---
34  1986 The use of the driving function in the analysis of endplate current kinetics. MEPCs
35  1985 The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. AChR, PHY
36  1984 A study of the novel synthetic analog (+/-)-depentylperhydrohistrionicotoxin on the nicotinic receptor-ion channel complex. AChR, HTX
37  1984 Effects of lead on neuromuscular transmission in the frog. ACh, EPPs
38  1984 Temperature effects on spontaneous and evoked quantal size at the frog neuromuscular junction. MEPCs
39  1984 The interaction between hexamethonium and tubocurarine on the rat neuromuscular junction. ACh, CCh, MEPCs, TC
40  1983 Comparative effects of clindamycin and lincomycin on end-plate currents and quantal content at the neuromuscular junction. ---
41  1983 Effects of serotonin (5-hydroxytryptamine) on amphibian neuromuscular junction. EPPs, MEPPs
42  1983 Effects of the aminoglycoside antibiotics, streptomycin and neomycin, on neuromuscular transmission. I. Presynaptic considerations. ---
43  1981 The action of polymyxin B at the frog neuromuscular junction. ---
44  1980 An attempt to distinguish between the actions of neuromuscular blocking drugs on the acetylcholine receptor and on its associated ionic channel. ---
45  1980 Effects of McN-A-343, a cholinomimetic drug, on endplate currents in the frog. ---
46  1979 Tetraethylammonium: voltage-dependent action on endplate conductance and inhibition of ligand binding to postsynaptic proteins. ---